Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precedex vs Midazolam/Remifentanil for Sedation in Ablation
NCT03451227Terminated
- Sponsor
- University Health Network
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in Atrial fibrillation (AFib) and atrial flutter (AFL), sponsored by University Health Network. Primary endpoint: Number of haemodynamic events requiring intervention at 24 hours. Started Dec 2017; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT03451227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451227.